Anticancer concept stocks

A brief review of anti-cancer concept stocks as of March 6, 20 15;

1. Hengrui Pharma has a complete product line, and its sales volume is the highest among many drugs. Including docetaxel (a new generation of plants), oxaliplatin (a new generation of platinum), letrozole (a new generation of excitotoxin) and so on. In addition to the new generation of plant felodipine, there are two targeted products: apatinib (clinical phase III to application for marketing) and famotidine (clinical phase II).

2. Laimei Pharmaceutical Co., Ltd., the exclusive product is nano-carbon suspension injection (lymphatic tracer), which is not a direct therapeutic drug; Fludarabine (anti-metabolism) and paclitaxel (plant) are also relatively new traditional chemical drugs. The products under research have advantages, including two new generation antimetabolites, decitabine and gemcitabine, temozolomide (new generation alkylating agent) and pectin adriamycin (antibiotic, targeted carrier).

3. Haizheng Pharmaceutical, the traditional drugs are mainly the new generation of antibiotics epirubicin, the old generation of adriamycin (antibiotics) and methotrexate (antimetabolism). The products under research include anti-CD20 recombinant humanized monoclonal antibody (targeted drug rituximab).

4. Shuanglu Pharmaceutical, traditional drugs include thymopentin and interleukin -2, which play an auxiliary role in immune regulation, and paclitaxel in plants, but it is not the main product. Temozolomide listed this year is a second imitation in China and has certain advantages. The products under study include targeted drug dasatinib, immunomodulator lenalidomide and antimetabolite clofarabine.

5. CITIC Guo Jian Lansheng Co., Ltd., which holds 15. 18% shares, is a leading enterprise in the monoclonal antibody industry in R&D and China, and its volume is increasing except for listed companies; Two kinds of monoclonal antibodies are applying for production approval, namely, rituximab, which ranks fourth in the world, and the imitation of herceptin, which ranks sixth. There are three kinds of monoclonal antibodies in clinical practice.

6. Tetracyclic organisms, related drugs include propranolol (recombinant human interleukin-2 injection), immunomodulatory drugs and adjuvant.

7. In anke biotechnology technology, the traditional drug is S- 1 (anti-metabolism), which is an earlier drug fluorouracil derivative (improved). Another recombinant human HER2 monoclonal antibody (targeted drug) is in the clinical stage, and many pharmaceutical companies have applied for clinical and marketing.

8. Fengyuan Pharmaceutical Co., Ltd. has announced that cisplatin, a new anticancer drug, will be listed before the end of September 2065438+2002, but there is no report to confirm that it has been listed.

9. ROP shares, bestv (ubenimex), immunomodulation.

10. Southwest Synthesis, the company cooperated with Founder Medical Research Institute to produce Combustine Disodium Phosphate (CA4P) and its injection, which are targeted drugs for blood vessels or drugs for endothelial injury (targeted drugs). Last year, domestic clinical phases II and III were approved, which is uncertain. In Europe and America, the drug has entered the third phase clinical trial of anti-lung cancer drugs and thyroid cancer, and other solid tumors have entered the second phase clinical trial.

1 1. Fosun Pharma, traditional drugs include antimetabolic drugs Pemetrexed Disodium and Foucault, hormone-based Ecolab and CHO HYE SUN, but they are not the main products of the company. The products under research mainly rely on external cooperation platforms: Shanghai Kaimao monoclonal antibody has not yet achieved results, Shanghai Fuhong Hanlin platform HLX0 1 (imitation rituximab, targeted drug) has completed clinical application for listing, and HLX02 has applied for clinical application.

12. Zhongxin Pharmaceutical Co., Ltd., Anfulong (second generation genetically engineered interferon α-2b), immunomodulation.

13. Hainan Haiyao, the traditional medicine is paclitaxel injection (plant); Bendamoustine hydrochloride for injection (a new generation of flower-washing agent) is in phase II clinical trial, belonging to class 3. 1 new chemical drug.

14. China resources Sanjiu, cinobufagin injection (traditional Chinese medicine).

15. Yuheng Pharmaceutical, a new generation of antimetabolite gemcitabine hydrochloride.

16. Renfu medicine, tumor necrosis factor-related apoptosis-inducing ligand TR- 1 medicine, gene medicine, under research.

17. Jilin aodong, preparation method of compound pancreatic ribonucleic acid for injection, immunomodulation.

18. Zhonghui Medicine, the company has two auxiliary Chinese medicines, Huang Chuan Oral Liquid and Gongliuqing Capsule.

17 lamiophlomis rotata, the company owns Gongliuning capsule (Chinese medicine). Shanghai Weike Bio, controlled by the actual controller Que Wenbin, may be injected into listed companies. "Tianenfu" of Vico Bio (recombinant human tumor necrosis factor for injection) is a new drug and targeted drug of 1.

18. Baiyi Pharmaceutical Co., Ltd. owns Aidi injection and Considi capsule, which are anti-tumor Chinese medicines. In terms of chemicals, there is the third generation of platinum, which is a major domestic manufacturer.

19. Neptune Bio, the company owns paclitaxel injection, oxaliplatin injection and calcium folinate for injection (auxiliary).

20. Haixin Co., Ltd. owns the therapeutic vaccine "antigen sensitized human dendritic cells (APDC)" for advanced colorectal cancer, which has been approved for phase III clinical application.

2 1. Harbin Pharmaceutical Co., Ltd., Huazheng Huisheng Oral Liquid (traditional Chinese medicine); Zhuanting Capsule (in clinic).

22. Pien Tze Huang and Pien Tze Huang capsules can be used for adjuvant treatment of liver cancer.

23. Jiangsu Wuzhong, recombinant human endostatin injection (targeted drug), national 1 new drug, clinical phase III.

24. Chinese ginseng group, Riccatin (iodine [13 1i] Metuximab injection), targeted drug.

25. Huabei Pharmaceutical has a new generation of antimetabolite epothilone, and its mechanism of action is the same as that of paclitaxel. Similar drugs of Bristol-Myers Squibb were approved to be listed in the United States in 2007.

26. Vingosine, recombinant human thymosin α 1, an immunomodulatory drug, has been completed for three years, but it has not been declared for production. 27. Taiji Group, paclitaxel injection, plants.

28. Xiangxue Pharmaceutical Co., Ltd. cooperated in the research and development of anti-tumor compound KX02, which may become an effective new drug for the treatment of brain tumors. However, it is still in the preclinical stage, with great uncertainty.

29. Zhendong Pharmaceutical, the exclusive product of the company, Compound Kushen Injection (Yan Shu Injection), is one of the mainstream anticancer drugs of traditional Chinese medicine.

30. Kangbain, a therapeutic vaccine for AFP (alpha-fetoprotein) project of liver cancer, is a targeted vaccine, but it is in the preclinical stage and has great uncertainty.

Yueyang Xingchang, a national first-class preventive drug developed by Wuhu Conway, a subsidiary of 3 1. Company, was approved in 2009 to prevent stomach diseases caused by Helicobacter pylori. Helicobacter pylori has the ability to cause stomach diseases and even gastric cancer.

32. Winbond Yingtai, calcium levofolinate for injection (auxiliary use) was approved.

33. zhifei Biotech is responsible for the exclusive distribution of Merck's preventive vaccine against human papillomavirus in Chinese mainland. The vaccine is still in the third clinical phase, and it is expected to be completed in 20 14. However, due to the time-consuming related procedures, the time to market will be later.

34. Tasly, temozolomide, a new generation of alkylating agent, the first generic drug in China; Flutamide tablets (the older generation of hormonal drugs).